Pluton Biosciences CEO Charlie Walch to Participate in Ag Innovation Roundtable as Part of STL Startup Week

Invest in Pluton...
Novel Solutions.
A Better World.

For more information about investment opportunities, please complete our Contact Us form below.

Pluton signed a research agreement with a major agriculture company to develop a new product in 2021. Stay tuned!

Pluton became the first St. Louis-based biotech company selected for the Illumina Accelerator, a company creation engine started by $50B San Diego-based, global DNA sequencing leader Illumina, Inc.

Pluton was selected to the Wells Fargo Innovation Incubator. Wells Fargo’s grant opened a collaboration with the Donald Danforth Plant Science Center’s biochemistry lab to identify the modes of action in our novel microbes with insecticidal activity.

Pluton entered into a co-development agreement with biotechnology company Evolugate to commercialize an all-natural mosquito larvicide.

Pluton Biosciences acquired Microbe Inotech Laboratories. The move provided a foundation for Pluton to build out its Micromining Innovation Engine while continuing the important pathogen testing work for Microbe Inotech’s legacy customers.